173 related articles for article (PubMed ID: 37053148)
1. History of key regulatory peptide systems and perspectives for future research.
Chen D; Rehfeld JF; Watts AG; Rorsman P; Gundlach AL
J Neuroendocrinol; 2023 Nov; 35(11):e13251. PubMed ID: 37053148
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-3 regulates corticotropin-releasing factor gene expression in cultured rat hypothalamic 4B cells.
Yagi H; Kageyama K; Kinoshita N; Niioka K; Yamagata S; Ito E; Daimon M
Neurosci Lett; 2019 Jan; 692():137-142. PubMed ID: 30412752
[TBL] [Abstract][Full Text] [Related]
3. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus.
Ceccatelli S; Eriksson M; Hökfelt T
Neuroendocrinology; 1989 Mar; 49(3):309-23. PubMed ID: 2469987
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptides and central control of sexual behaviour from the past to the present: a review.
Argiolas A; Melis MR
Prog Neurobiol; 2013 Sep; 108():80-107. PubMed ID: 23851261
[TBL] [Abstract][Full Text] [Related]
5. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies.
Ma S; Gundlach AL
Adv Exp Med Biol; 2007; 612():119-37. PubMed ID: 18161485
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the signaling system in relaxin-family peptides.
Hsu SY; Semyonov J; Park JI; Chang CL
Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
[TBL] [Abstract][Full Text] [Related]
7. Endocrine cells producing regulatory peptides.
Solcia E; Usellini L; Buffa R; Rindi G; Villani L; Zampatti C; Silini E
Experientia; 1987 Jul; 43(7):839-50. PubMed ID: 3297770
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptides, hormone peptides, and their receptors in Ciona intestinalis: an update.
Kawada T; Sekiguchi T; Sakai T; Aoyama M; Satake H
Zoolog Sci; 2010 Feb; 27(2):134-53. PubMed ID: 20141419
[TBL] [Abstract][Full Text] [Related]
9. [Neuropeptides in Alzheimer's disease].
Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H
Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772
[TBL] [Abstract][Full Text] [Related]
10. Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone.
Tritos NA; Maratos-Flier E
Neuropeptides; 1999 Oct; 33(5):339-49. PubMed ID: 10657511
[TBL] [Abstract][Full Text] [Related]
11. Teneurin C-terminal associated peptides: an enigmatic family of neuropeptides with structural similarity to the corticotropin-releasing factor and calcitonin families of peptides.
Lovejoy DA; Al Chawaf A; Cadinouche MZ
Gen Comp Endocrinol; 2006 Sep; 148(3):299-305. PubMed ID: 16524574
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the growth hormone-releasing factor (GRF) family of peptides.
Campbell RM; Scanes CG
Growth Regul; 1992 Dec; 2(4):175-91. PubMed ID: 1290954
[TBL] [Abstract][Full Text] [Related]
13. Evidence that corticotropin-releasing hormone acts as a growth hormone-releasing factor in a primitive teleost, the European eel (Anguilla anguilla).
Rousseau K; Le Belle N; Marchelidon J; Dufour S
J Neuroendocrinol; 1999 May; 11(5):385-92. PubMed ID: 10320566
[TBL] [Abstract][Full Text] [Related]
14. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical detection of cholecystokinin and corticotrophin-releasing hormone neuropeptides in the hypothalamic paraventricular nucleus of the jerboa (Jaculus orientalis): modulation by immobilisation stress.
Barakat Y; Pape JR; Boutahricht M; El Ouezzani S; Alaoui A; Chaigniau M; Tramu G; Magoul R
J Neuroendocrinol; 2006 Oct; 18(10):767-75. PubMed ID: 16965295
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptides in the amphibian brain.
Andersen AC; Tonon MC; Pelletier G; Conlon JM; Fasolo A; Vaudry H
Int Rev Cytol; 1992; 138():89-210, 315-26. PubMed ID: 1280630
[No Abstract] [Full Text] [Related]
17. Hypothalamic hormones a.k.a. hypothalamic releasing factors.
Guillemin R
J Endocrinol; 2005 Jan; 184(1):11-28. PubMed ID: 15642779
[TBL] [Abstract][Full Text] [Related]
18. Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.
Zhang C; Baimoukhametova DV; Smith CM; Bains JS; Gundlach AL
Psychopharmacology (Berl); 2017 Jun; 234(11):1725-1739. PubMed ID: 28314951
[TBL] [Abstract][Full Text] [Related]
19. Neuroactive peptides: unique phases in research on mammalian brain over three decades.
Myers RD
Peptides; 1994; 15(2):367-81. PubMed ID: 8008641
[TBL] [Abstract][Full Text] [Related]
20. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
